Preprint · OA
via OpenAlex
Disruption of the Choroid Plexus Circadian Rhythm’s in Alzheimer’s Disease
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 2019
Abstract
Alzheimer´s disease (AD) is a neurodegenerative disorder, characterized by amyloid beta (Abeta) and tau protein deposition in the brain parenchyma and blood vessels. Abeta accumulation in areas of the brain controlling circadian rhythms can delay or shift activity rhythms. The circadian rhythm is coordinated by the master circadian pacemaker located in the suprachiasmatic nucleus (SCN) of the hypothalamus. The choroid plexus (CP), a recent characterized extra-SCN circadian oscillator, is also known to exhibit morphological changes in AD which are exacerbated by the presence of Abeta deposits in CP epithelial cells. Melatonin is a hormone secreted by the pineal gland and there’s some evidence that, in AD patients, the circulating levels of this hormone are diminished. Under normal circumstances, melatonin acts as a neuroprotector against AD, but how this protection occurs is still to be fully comprehended. It also acts as a Zeitgeber, synchronizing the rhythms of the circadian genes, regulating the body’s circadian clocks. In this study we addressed the question whether Abeta contributes to CP’s circadian clock disruption and if melatonin modulates circadian clock genes expression therein. Using an AD mouse model (APP/PS1), we investigated changes in the expression of CP clock genes at different time points, in female and male animals, aged 6 and 12 months old. In addition, in vitro studies using Z310 cell line treated with Abeta and melatonin were used to examine if melatonin modulated Bmal1 circadian expression. We demonstrated that only Bmal1 circadian expression is altered in AD mice model 12 months old. Contrarily, Cry2 and Per2 expression were not affected in the APP/PS1 model. In addition, we found that melatonin modulated several parameters in the circadian expression of Bmal1. These results indicate that Abeta deposition on the CP disrupted the rhythmic circadian expression of Bmal1 and that melatonin modulates CP clock gene circadian rhythms in the presence of Abeta.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Furtado, A. (2019). Disruption of the Choroid Plexus Circadian Rhythm’s in Alzheimer’s Disease. <em>Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)</em>. https://openalex.org/W3012945008
Vancouver
Furtado A. Disruption of the Choroid Plexus Circadian Rhythm’s in Alzheimer’s Disease. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2019.
BibTeX
@unpublished{andr2019Disrup,
title = {Disruption of the Choroid Plexus Circadian Rhythm’s in Alzheimer’s Disease},
author = {André Furtado},
journal = {Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurodegeneration 2015
Open access · CC-BY
Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease
Occupational and Environmental Medicine 1997
Open access · OA
Aging, rhythms of physical performance, and adjustment to changes in the sleep-activity cycle.
Experimental Neurology 2017
Open access · CC-BY
Disruption of normal circadian clock function in a mouse model of tauopathy
PubMed Central 2001
Preprint · CC0
Overview of circadian rhythms.
Experimental Neurology 2012
Citation only
Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease
Nutrients 2024
Open access · CC-BY